BNP Paribas’s Cardinal Health CAH Stock Holding History

BNP Paribas’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-50	Closed	-$5.53K	–	379
2024 Q3	$5.53K	Buy	+50	New	+$5.23K	﹤0.01%	329

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BNP Paribas's CAH Position: Q4 2024 in Review

BNP Paribas sold out of Cardinal Health (CAH) in Q4 2024, closing a stake of 50 shares — an estimated $5.53K sold.

BNP Paribas first reported a position in CAH in Q3 2024 and held it in 1 quarter. The position peaked at $5.53K in Q3 2024. 1,097 funds tracked by Wall St. Rank hold CAH as of Q4 2024.

BNP Paribas reported no remaining Cardinal Health position as of Q4 2024 after selling out during the quarter.
BNP Paribas sold 50 Cardinal Health shares in Q4 2024, an estimated $5.53K.
BNP Paribas first reported a position in Cardinal Health in Q3 2024 and held it in 1 quarter.
BNP Paribas's Cardinal Health position peaked at $5.53K in Q3 2024.
1,097 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2024.

Based on BNP Paribas's 13F filing for Q4 2024, filed 14 Feb 2025.